Bio-Rad Laboratories, Inc. logo
Bio-Rad Laboratories, Inc. (BIO)
Compare

Bio-Rad Laboratories, Inc. (BIO) Earnings Per Share (EPS): 6.07

Is Bio-Rad Laboratories, Inc.’s earnings per share (EPS) high or low?

Bio-Rad Laboratories, Inc.'s earnings per share (EPS) of 6.07 is 59% below its 5-year average of 14.90, around the middle of its 5-year range (-121.79–142.61).

The earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO) is 6.07 as of Wednesday, June 10, 2026. It is above its 12-month average by 132.38% (-18.74).

BIO Earnings Per Share (EPS) Chart

BIO Earnings Per Share (EPS)
27.87+142.64% 1Y
Zoom

BIO Average Earnings Per Share (EPS) Chart

BIO Current vs Average Earnings Per Share (EPS) Chart

BIO Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

6.07

EARNINGS PER SHARE (EPS) AVG TTM

-18.74

EARNINGS PER SHARE (EPS) AVG 3Y

-45.28

EARNINGS PER SHARE (EPS) AVG 5Y

14.90

EARNINGS PER SHARE (EPS) AVG 10Y

15.38

EARNINGS PER SHARE (EPS) AVG 15Y

12.12

EARNINGS PER SHARE (EPS) AVG 20Y

10.14

CURRENT VS TTM AVG

+132.38%

CURRENT VS 3Y AVG

+113.41%

CURRENT VS 5Y AVG

-59.25%

CURRENT VS 10Y AVG

-60.52%

CURRENT VS 15Y AVG

-49.91%

CURRENT VS 20Y AVG

-40.15%

BIO Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
Bio-Rad Laboratories, Inc. (BIO)$7.89B6.07-18.74-45.2814.90
Charles River Laboratories International, Inc. (CRL)$9.06B-3.76-1.354.035.21
Hims & Hers Health, Inc. (HIMS)$6.42B-0.090.570.18-0.06
Baxter International Inc. (BAX)$10.49B-2.10-1.51-0.650.36
Align Technology, Inc. (ALGN)$12.56B5.965.645.439.01
Hologic, Inc. (HOLX)$16.97B2.402.923.224.07
Moderna, Inc. (MRNA)$18.40B-8.15-8.27-1.903.46
BioNTech SE (BNTX)$21.81B-5.94-4.089.2114.48
Mettler-Toledo International Inc. (MTD)$22.85B42.7141.4239.4336.04
Waters Corporation (WAT)$23.83B7.8710.7811.0510.65

EPS Comparison

Trailing EPS (TTM)

$6.07

Forward EPS (Est.)

$9.96

P/E Ratio

48.1

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

Bio-Rad Laboratories, Inc. Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Bio-Rad Laboratories, Inc. Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The earnings per share (EPS) for BIO stock is 6.07.
Is Bio-Rad Laboratories, Inc.'s earnings per share (EPS) high or low?
Bio-Rad Laboratories, Inc.'s earnings per share (EPS) of 6.07 is 59% below its 5-year average of 14.90, around the middle of its 5-year range (-121.79–142.61).
What is the TTM average earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The TTM average earnings per share (EPS) for BIO stock is -18.74.
What is the 3Y average earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The 3Y average earnings per share (EPS) for BIO stock is -45.28.
What is the 5Y average earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The 5Y average earnings per share (EPS) for BIO stock is 14.90.
What is the 10Y average earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The 10Y average earnings per share (EPS) for BIO stock is 15.38.
What is the 15Y average earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The 15Y average earnings per share (EPS) for BIO stock is 12.12.
What is the 20Y average earnings per share (EPS) for Bio-Rad Laboratories, Inc. (BIO)?
The 20Y average earnings per share (EPS) for BIO stock is 10.14.

Bio-Rad Laboratories, Inc. Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2025-12-3127.87
2024-12-31-65.36
2023-12-31-21.82
2022-12-31-121.79
2021-12-31142.61
2020-12-31127.86
2019-12-3158.93
2018-12-3112.10
2017-12-314.12
2016-12-310.88
2015-12-313.74
2014-12-313.08
2013-12-312.72
2012-12-315.85
2011-12-316.39
2010-12-316.70
2009-12-315.28
2008-12-313.30
2007-12-313.48
2006-12-313.92
2005-12-313.13
2004-12-312.65
2003-12-313.00
2002-12-312.70
2001-12-311.79
2000-12-311.27
1999-12-310.49
1998-12-310.99
1997-12-310.67
1996-12-311.07

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA
7,700 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz